![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1675389
EDC ½Ã½ºÅÛ(ÀüÀÚ µ¥ÀÌÅÍ Ä¸Ã³ ½Ã½ºÅÛ) ½ÃÀå : Á¦°ø ¸ðµåº°, ÄÄÆ÷³ÍÆ®º°, °³¹ß ´Ü°èº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°(2025-2033³â)Electronic Data Capture Systems Market Report by Delivery Mode, Component, Development Phase, End User, and Region 2025-2033 |
¼¼°èÀÇ EDC ½Ã½ºÅÛ(ÀüÀÚ µ¥ÀÌÅÍ Ä¸Ã³ ½Ã½ºÅÛ) ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 14¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº ÀÌ ½ÃÀåÀÌ 2033³â±îÁö 33¾ï ´Þ·¯¿¡ ´ÞÇϸç, 2025-2033³â¿¡ 9.7%ÀÇ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÓ»ó½ÃÇèÀÇ ±Þ¼ÓÇÑ µðÁöÅÐÈ, Ŭ¶ó¿ìµå ±â¹Ý ½Ã½ºÅÛÀÇ Ã¤Åà Áõ°¡, ¸ð¹ÙÀÏ EDCÀÇ µµÀÔÀº ½ÃÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀÇ ÀϺÎÀÔ´Ï´Ù.
EDC ½Ã½ºÅÛÀº ÀÓ»ó½ÃÇè µ¥ÀÌÅ͸¦ ÀüÀÚÀû ÇüÅ·Π¼öÁýÇÏ°í °ü¸®Çϱâ À§ÇØ ¼³°èµÈ ¼ÒÇÁÆ®¿þ¾î Åø·Î, ȯÀÚ ¼Ó¼º, º´·Â, ºÎÀÛ¿ë, °Ë»ç °á°ú, ÀÓ»ó °á°ú Æò°¡, ÀüÀÚµ¿ÀǼ(eConsent), ÀÓ»ó½ÃÇè ½Ç½Ã±â°ü Á¤º¸ µî ´Ù¾çÇÑ µ¥ÀÌÅ͸¦ ¼öÁýÇÕ´Ï´Ù. EDC ½Ã½ºÅÛÀº ±ÔÁ¦ ´ç±¹, ÀÓ»ó½ÃÇè ÀÇ·ÚÀÚ, ÀÓ»ó½ÃÇè ¼öʱâ°ü(CRO), ÀÓ»ó½ÃÇè Âü¿©ÀÚ ¹× µ¥ÀÌÅÍ °ü¸®ÀÚ°¡ ³Î¸® »ç¿ëÇϰí ÀÖÀ¸¸ç, µ¥ÀÌÅÍ ¼öÁý °£¼ÒÈ, µ¥ÀÌÅÍ Ç°Áú Çâ»ó, ÀÎÀû ¿À·ù ÃÖ¼ÒÈ, ±â¹Ð Á¤º¸ º¸È£, µ¥ÀÌÅÍ À¯Ãâ ¹× Áߺ¹ À§Çè °¨¼Ò¿¡ µµ¿òÀÌ µË´Ï´Ù. EDC ½Ã½ºÅÛÀº ¶ÇÇÑ ÀÓ»ó½ÃÇèÀÇ È¿À²¼ºÀ» ³ôÀ̰í, ½Ç½Ã°£ ¸ð´ÏÅ͸µ ±â´ÉÀ» Á¦°øÇϸç, ÀÇ»ç°áÁ¤À» Áö¿øÇϰí, µ¥ÀÌÅÍÀÇ Á¤È®¼º, ½Å·Ú¼º, Àϰü¼ºÀ» º¸ÀåÇÕ´Ï´Ù.
EDC ½Ã½ºÅÛÀº µ¥ÀÌÅÍ ¼öÁý, ÀúÀå, ¸ð´ÏÅ͸µ, ºÐ¼® µî ´Ù¾çÇÑ ÀÓ»ó½ÃÇè ¾÷¹«ÀÇ ÀÚµ¿È¿¡ ³Î¸® Ȱ¿ëµÇ°í ÀÖÀ¸¸ç, À̸¦ ÅëÇØ ÇÁ·Î¼¼½º °¡¼ÓÈ, Åõ¸í¼º Çâ»ó, ¿À·ù ¹æÁö, Àü¹ÝÀûÀÎ È¿À²¼º Çâ»ó, µ¥ÀÌÅÍ ¼öÁý, ÀúÀå, ¸ð´ÏÅ͸µ, ºÐ¼® µî ´Ù¾çÇÑ ÀÓ»ó½ÃÇè ¾÷¹«ÀÇ ÀÚµ¿È¿¡ Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀÎ È¿À²È¸¦ ½ÇÇöÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ´ç´¢º´, °íÇ÷¾Ð, ¾ËÃ÷ÇÏÀ̸Ӻ´, ´Ù¹ß¼º °æÈÁõ, ½ÉÇ÷°ü Áúȯ(CVDs)°ú °°Àº ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇÑ »õ·Î¿î Ä¡·á¹ý ¹× Ä¡·áÁ¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡µµ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ºñ¿ë È¿À²ÀûÀ̰í, »ç¿ëÀÚ Ä£ÈÀûÀ̸ç, È®Àå °¡´ÉÇϰí, ¾ÈÀüÇϸç, ½Ç½Ã°£À¸·Î µ¥ÀÌÅÍ¿¡ Á¢±ÙÇÒ ¼ö Àִ Ŭ¶ó¿ìµå ±â¹Ý ½Ã½ºÅÛÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ´Â °Íµµ ½ÃÀå ¼ºÀå¿¡ ź·ÂÀ» ÁÖ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½º¸¶Æ®Æù ¹× ÅÂºí¸´À» ÀÌ¿ëÇÑ ¸ð¹ÙÀÏ EDCÀÇ µµÀÔÀº ȯÀÚ µ¥ÀÌÅ͸¦ ¼öÁýÇÏ´Â Æí¸®ÇÏ°í ºñ¿ë È¿À²ÀûÀÎ ¹æ¹ýÀ¸·Î Âü¿©µµ¸¦ ³ôÀ̰í, ÄÄÇöóÀ̾𽺸¦ °ÈÇϸç, ¿À·ùÀÇ À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ½ÃÀå ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. À̿ʹ º°µµ·Î, µ¥ÀÌÅÍ ºÐ¼®À» °³¼±ÇÏ°í ½Å¼ÓÇÑ ÀÇ»ç°áÁ¤À» °¡´ÉÇÏ°Ô ÇÏ¸ç ÆÐÅÏ, Ãß¼¼, ÀÌ»ó ¡Èĸ¦ ½Äº°Çϱâ À§ÇÑ ¸Ó½Å·¯´×(ML)°ú ÀΰøÁö´É(AI)ÀÇ ÅëÇÕÀº ½ÃÀå ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÓ»ó½ÃÇè µ¥ÀÌÅÍÀÇ ¾ÈÀü°ú ¹«°á¼º¿¡ ´ëÇÑ ¾ö°ÝÇÑ Á¤ºÎ ±ÔÁ¦°¡ ½ÃÇàµÇ¸é¼ ±ÔÁ¦ ´ç±¹ÀÇ ÄÄÇöóÀ̾𽺠°È¸¦ Áö¿øÇÏ´Â EDC¿Í °°Àº °í±Þ µ¥ÀÌÅÍ °ü¸® ¹× º¸°í ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ °³ÀÎ ¸ÂÃãÇü ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ±¤¹üÀ§ÇÑ R&D Ȱµ¿, ȯÀÚ Á᫐ ÀÓ»ó½ÃÇè¿¡ ´ëÇÑ °ü½É Áõ°¡ µîÀÌ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
The global electronic data capture (EDC) systems market size reached USD 1.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.3 Billion by 2033, exhibiting a growth rate (CAGR) of 9.7% during 2025-2033. The rapid digitalization of clinical trials, the rising adoption of the cloud-based system, and the introduction of mobile-EDC represent some of the key factors driving the market.
Electronic data capture (EDC) systems refer to software tools designed to collect and manage clinical trial data in electronic format. They capture a wide variety of data, including patient demographics, medical history, adverse events, laboratory results, clinical outcome assessments, electronic informed consent (eConsent), and study site information. EDC systems are widely used by regulatory agencies, clinical trial sponsors, contract research organizations (CROs), trial participants, and data managers. They help streamline data collection, improve data quality, minimize human errors, protect sensitive information, and reduce the risk of data loss and duplications. EDC systems also enhance the efficiency of the clinical trial, provide real-time monitoring capabilities, assist in decision-making, and ensure data accuracy, reliability, and consistency.
The rapid digitalization of clinical trials across the globe is one of the primary factors propelling the market growth. EDC systems are widely used to automate various clinical trial operations, such as data collection, storage, monitoring, and analysis, which, in turn, accelerate the process, provide transparency, prevent errors, and improve overall efficiency. In addition to this, the growing demand for new treatments and therapeutics due to the increasing prevalence of chronic diseases, such as diabetes, hypertension, Alzheimer's disease, multiple sclerosis, and cardiovascular diseases (CVDs), are acting as another growth-inducing factor. Furthermore, the rising adoption of the cloud-based system, which is cost-effective, user-friendly, scalable, highly secure, and offers real-time access to data, is providing an impetus to the market growth. Additionally, the introduction of mobile-EDC, which utilize smartphones or tablets as a convenient and cost-effective way to collect patients' data, thus improving engagement, increasing compliance, and reducing the risk of errors, is favoring the market growth. Apart from this, the integration of machine learning (ML) and artificial intelligence (AI) to improve data analysis, enable faster decision-making, and identify patterns, trends, and anomalies is positively influencing the market growth. Moreover, the implementation of stringent government regulations regarding the safety and integrity of clinical trial data is facilitating the demand for advanced data management and reporting systems, such as EDC, which aids in ensuring greater compliance with the authorities. Other factors, including increasing demand for personalized medicines, extensive research and development (R&D) activities, and the growing focus on patient-centric clinical trials, are anticipated to drive the market growth.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.